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Damageto Hepatic Cellular Membranes
by Chlorinated Olefins with Emphasis
on Synergism and Antagonism
by Edward S. Reynolds* and Mary Treinen Moslen*
The fundamental reactivity or stability ofthe chloroethylene molecules affects their hepatotoxic poten-
tial. Extent and symmetry ofthechlorine substitution, which alters electron delocalization, charge polari-
zation, and solubility, affect biologic response. The most nonsymmetrically depolarized chloroethylene,
1,1-dichloroethylene (1,1-DCE) is the most hepatotoxic and causes a unique pattern of hepatoceliular
injury involving mitochondria, plasma membranes, and chromatin. The injury caused by the other
chloroethylenes examined appears to profoundly affect the structural integrity of the endoplasmic re-
ticulum with toxic potential in the order: trichloroethylene (TRI) > vinyl chloride (VCM) > per-
chloroethylene (PER). Pretreatments which increased cytochrome P450 contents, thus presumably aug-
menting metabolic activation to a reactive intermediate such as an epoxide, enhanced or were synergistic
to the hepatotoxic potential of TRI, VCM and PER but were protective or antagonistic to 1,1-DCE
hepatotoxicity. Biologic response to 1,1-DCE may be expressed by a different metabolic pathway.
Glutathione appears to be involved in thebiologic response toalH nonsymmetricchloroethylenes and to act
as an antagonist against injury. Marked differences in the patterns ofinjury and the biologic responses
suggest that more than one mechanism is involved in the production ofinjury by chloroethylenes.
Introduction
Our studies of the acute hepatotoxicity of the
chloroethylenes have shown not only certain
similarities in their biologic effects, but marked dif-
ferences in both relative toxicity and in the pattern
of hepatocellular injury. These marked differences
suggest that the chloroethylenes produce injury by
more than one mechanism. The relative reactivity
ofthese molecules is affected by the extent to which
their electron distribution is altered by chlorine sub-
stitution. Two effects are involved. First, the more
electronegative halogens attract electrons. Second,
the orbital ofone ofthe lone pairs ofelectrons ofthe
chlorine atom overlaps with the pi electrons of the
carbon-carbon double bond. This interaction in-
volves a partial loss of electrons by the chlorine
atom and again by the double bond as illustrated by
the small curved arrows in Figure 1 (1). The result is
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that the carbon-chlorine bond acquires some dou-
ble bond character and the molecule become
polarized as shown for vinyl chloride (VCM). When
two chlorine atoms are attached to one carbon of
the double bond, as with l,l-dichloroethylene
(I,1-DCE), the net electron delocalization is en-
hanced. A more polarized molecule results. On the
other hand, symmetrical attachment of the
chlorines to both carbons of the double bond leads
to a more uniform electron delocalization, as illus-
trated by the four resonance forms of per-
chloroethylene (PER), resulting in a more stable
molecule. For trichloroethylene (TRI), electron
delocalization would be less extreme than for 1,1-
DCE but more marked than for PER and some-
what similar to VCM. Increasing chlorine substitu-
tion also alters the biologic response to this series of
chloroethylenes by increasing the lipid solubility
and by depressing the volatility or "exhalability."
Our semiquantitative analysis of these factors
(molecular reactivity/stability, lipid solubility and
volatility) indicates an order of toxicity: l,1-DCE
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FIGURE 1. Substitution of chlorine atoms for hydrogen atoms
affects the electron distribution ofchloroethylene molecules.
Electrons are attracted to the more electro-negative halogen
atom. Another factor must also be considered for the orbital
(position in space) of one ofthe lone pairs ofelectrons ofthe
chlorine atom overlaps with the orbital of the pi electrons of
the carbon to carbon double bond. The small curved arrows
illustrate this phenomenon as movement of the electrons as-
sociated with the chlorine to the carbon to chlorine bond
coupled with movement of electrons in the double bond to-
wards the other carbon. This shift of electrons causes a
polarization of the molecule as indicated by the partial
charges. The chlorine to carbon bond has some double bond
character as indicated by the dashed bonding lines. Sym-
metry and extent ofchlorine substitution which alter both the
degree of molecular polarization and of electron delocaliza-
tion affect the molecular stability/reactivity. Principles ofthe
chloroethylene electron delocalization and description of re-
sulting molecular polarization from Musgrave (I).
>> TRI > VCM > PER. Fortunately, this ranking
corresponds to our experimental assessment of the
acute hepatotoxicity potential of these four
chloroethylenes.
We approached the study of the biochemical
mechanism(s) responsible for the toxicity of the
chlorinated olefins by pretreating animals with
chemicals which modify components of the liver
mixed-function oxidase system, the enzyme system
most likely to be involved in the initial biotransfor-
mation of lipid-soluble xenobiotics. We hoped that
determination of factors which were synergistic or
enhancing of the hepatotoxic potential would indi-
cate the mechanism ofactivation, while determina-
tion offactors which were antagonistic or protective
against the hepatotoxic course would clarify the
nature of the reactive molecular species. Our
working hypothesis was that the hepatotoxic po-
tential ofthese chloroethylenes would be modulated
by pretreatments which nonuniformly enhance
and/or uncouple the enzymatic components in-
volved in biotransformation of these chloro-
ethylenes to excretable products via reactive inter-
mediates such as epoxides or aldehydes. Powell (2)
first suggested an epoxide intermediate for the
metabolism ofTRI in 1945. Liebman and colleagues
(3-5) had already demonstrated that the liver
mixed-function oxidase system is involved in the
initial biotransformation of TRI, and that pretreat-
ment with phenobarbital (PBT) causes alterations in
the rate and route of TRI metabolism. Carlson (6)
reported that pretreatment with PBT or
3-methylcholanthrene (3-MC) exacerbates the
hepatotoxicity of TRI.
Methods
Ourbasic experimental procedure utilizes a7-day
gavage pretreatment of200 g male Sprague Dawley
rats with one of six agents: 400 ,mole/kg isomolar
doses of PBT, 3-MC, hexachlorobenzene (HCB),
spironolactone (SNL) or pregnenolone-16a-
carbonitrile (PCN) or 150 ,mole/kg of Aroclor
1254. Control animals are given the administrative
vehicle (5 mI/kg of0.1% Tween 80). The animals are
then fasted overnight and on the morning of day 8
sacrificed for determination of microsomal enzyme
components or exposed to one of the
chloroethylenes. Similarly pretreated "controls"
are exposed only to room air. Details of pretreat-
ment conditions, microsomal enzyme component
assays, other chemical analyses, chloroethylene
exposure techniques, histologic examination and
methods to quantitate liver injury using serum
transaminase activities or liver metal contents have
been described (7, 8). Chloroethylene exposures
were: VCM (5% x 6 hr), l,l-DCE (0.02% x 4 hr),
TRI (1% x 2 hr) and PER (7.5 mmole/kg, PO).
Microsomal enzyme components assayed included:
cytochrome P450 and b5, cytochrome c reductase
by NADPH and NADH, oxidative N-de-
methylation of dimethylaminoantipyrine and
ethylmorphine, glucose 6-phosphatase, and aryl
hydrocarbon hydroxylation of zoxazolamine and
3,4-benzpyrene. The six "agents" chosen to modify
the liver mixed function oxidase system gave six
different patterns of enzyme induction (7, 8).
Results of Parallel Studies
Our working hypothesis proved rational. The
acute hepatotoxicity of these four chloroethylenes
was modulated to different extents in the animals
pretreated with the six inducing agents as compared
to the control animals given the administrative ve-
hicle. To determine if induction ofa specific mixed
function oxidase system component was associated
with modulation of chloroethylene-induced liver
injury, we compared mean enzyme component
levels (assayed at times compatible with onset of
chloroethylene administration) with mean serum
transaminase levels of similarly pretreated animals
sacrificed afterchloroethylene exposure. There was
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P-450 contents and mean serum glutamic oxalo-
acetic transaminase (SGOT) activities 24 hr after
TRI exposure (significance < 1%, df = 5, r = 0.95)
by linear regression analysis or the power regres-
sion analysis shown in Figure 2 (bottom) (8). There
was a less perfect correlation (significance -5%, df
= 5, r = 0.73) between mean rates of reduction of
cytochrome P-450 by NADPH (measured as
NADPH-cytochrome c reductase) and SGOT24 hr
after TRI. No other relationship between a mixed
function oxidase component and SGOT after TRI
exposure was apparent. In this study we also found
that the extent of SGOT elevation in individual
animals correlated to prolongation ofanesthesia re-
covery time after TRI exposure and to enhanced
urinary excretion of trichlorinated metabolites. We
concluded that the relative degree of TRI-induced
liver injury related directly to cytochrome P450
content at the time ofexposure and to the extent of
TRI biotransformation.
Since PER was considered to be a more stable
molecule and thus to have a lesser potential for
metabolic activation to a reactive species, we
looked for augmentation of PER-induced injury
only in animals pretreated with PBT or Aroclor
1254, the most potent inducers of cytochrome
P450. While urinary recoveries of total trichlori-
nated products were approximately 5- and 7-fold
greater in the PBT- and Aroclor 1254-pretreated
animals compared to the vehicle-pretreated "con-
trol" animals, only in Aroclor 1254-pretreated rats
did we find evidence ofPER-induced liver injury in
terms of SGOT elevation and focal histologic ne-
crosis (8).
As shown at the top of Figure 2, pretreatments
which were potent inducers of cytochrome P450
also enhanced the hepatotoxicity of VCM as re-
flected by elevated activities of serum alanine
a-ketoglutarate transaminase (SAKT) 24 hr after
VCM exposure (7). This relationship was signifi-
cant at --1% level.
Pretreatment with inducers of cytochrome P450
had a diametrically opposite effect on the response
of animals to 1,1-DCE exposure (Fig. 2, middle)
(7). Essentially, as mean cytochrome P450 content
increases, the hepatotoxic effect of 1,-DCE de-
creases as reflected by SAKT activities, histologic
appearance, and liver metal contents of animals
sacrificed 6 hr after onset of 1,l-DCE. Again there
were correlations of lesser significance (-5%) be-
tween mean rates ofreduction ofcytochrome P450
by NADPH and the mean SAKT activities after
exposure to VCM or 1J,-DCE. Attempts to corre-
late other mixed function oxidase components with
SAKT activities after VCM or 1,1-DCE exposure
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FIGuPRE 2. Correlations between mean liver microsomal cyto-
chrome P450 contents at the beginning of chloroethylene
exposure and the mean serum enzyme transaminase activities
after chloroethylene exposure in groups ofanimals pretreated
with one of six inducers of mixed function oxidase compo-
nents plus the "control" animals pretreated with the adminis-
trative vehicle: (0) control; (.) PBT; (O) Aroclor 1254; (U)
HCB; (A) 3-MC; (A) SNL; (o) PCN. Top correlation is
between increasing cytochrome P-450 contents and elevated
SAKT activities 24 hr after onset of VCM exposure (signifi-
cant at the 1% level, df = 5). Middle correlation is between
decreasing cytochrome P-450 contents and elevated SAKT
activities 6 hr after onset of 1 Il-DCE exposure (significant at
the 1% level, df = 5). Bottom correlation between increasing
cytochrome P-450 contents and elevated SGOT activities 24
hr after onset of TRI exposure is a power relationship such
that within the experimental range each 2-fold increase in
cytochrome P-450 corresponds approximately to a 10-fold
increase in SGOT (significant at < 1% level, df = 5). Data for
the VCM and 1,I-DCE correlations from Reynolds et al. (7).
Data for the TRI correlation from Moslen et al. (8)
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FIGURE 3. Midzonal parenchymal cells 2 hr after the onset ofexposure to 0.02% DCE. Cell borders are retracted from sinusoidal walls
at upper left and center right. Space formed contains cytoplasmic protrusions, material resembling fibrin and erthyrocytes. Cyto-
plasm ofretracted cells focally contains swollen mitochondria and clusters of small vacuoles in the regions ofthe golgi apparatus.
Strands of rough endoplasmic reticulum are intact. Nuclei show striking segregation of chromatin towards the margins of the
nuclear envelope. Bile canaliculi appear intact. x 6,000.
resulted in non-significant scattergrams. It should
be pointed out that the amount of 1,I-DCE (0.02%
x 4 hr) to which the animals were exposed was
much less than that ofTRI (1% x 2 hr), which was
in turn much less than the amount ofVCM (5% x 6
hr) administered. Our experimental studies with
VCM, l,l-DCE, TRI, and PER as well as the
comparative microsomal enzyme component
140
analyses were essentially concurrent using overlap-
ping series of similarly pretreated animals.
Differences in Acute
Hepatic Injury
Because of the differences in the basic molecular
stability/reactivity of the four chloroethylenes as
Environmental Health PerspectivesFIGURE 4. Portion of centrolobular liver cells of PBT pretreated animals 8 hr after onset of exposure to TRI (1%, 2 hr). Rough
endoplasmic reticulum in perinuclear regions of parenchymal cells is vacuolated and smooth is condensed into tangled tubular
masses flecked with areas of increased electron opacity ("labyrinthine" tubular aggregates). x 20,000. Inset on bottom. Higher
power of tangled tubular masses. Tubular diameters show greatest narrowing in areas ofincreased electron opacity. Radioopaque
material appears applied on outer surfaces of tubular profiles. x 120,000.
December 1977 141illustrated in Figure 1, variations were expected in
the biologic response to these molecules specifically
in the extent ofbiotransformation, type and stability
of intermediate(s), and ultimate excreted products.
Such factors could contribute to the differences
found in the nature of the hepatocellular injury.
Hepatic injury following 1,1-DCE (0.02% x 4 hr)
occurs abruptly and first appears as a prominent
midzonal stripe of necrosis which rapidly evolves
into hemorrhagic centrolobular necrosis by the end
of the 4-hr exposure (7). As shown in Figure 3,
parenchymal cell injury is apparent 2 hr after onset
of l,l-DCE exposure and is characterized by
retraction of cell borders with the formation of a
pericellular "lacunae" which may contain cyto-
plasmic projections, red blood cells and fibrin. Nu-
clear changes in such cells are striking with loss of
perinucleolar chromatin, and clumping and coales-
cence of perinuclear chromatin into cresentric de-
posits of electron-opaque material against the nu-
clear envelope. Mitochondria in the cytoplasm of
such cells appear swollen and outer mitochondrial
membranes are ruptured. In contrast, rough and
smooth endoplasmic reticulum appear relatively
normal.
Hepatocellular structural derangement following
TRI exposure (1% x 2 hr) in PBT-pretreated ani-
mals presents in a different form than I ,1-DCE with
increased cytoplasmic disorder, random dispersion
of organelles including ergastroplasm and degranu-
lation and vacuolization of rough endoplasmic re-
ticulum (9). Smooth endoplasmic reticulum then
coalesces into tubular aggregates. By 8 hr after the
onset of TRI exposure, coalescent tangles of
smooth endoplasmic reticulum membranes contain
electron-opaque regions suggestive of membrane
collapse (Fig. 4). Vacuolization of rough endoplas-
mic reticulum is also found in PBT and Aroclor
1254 animals after PER administration. Similar
patterns of endoplasmic reticulum denaturation
were found in PBT and Aroclor 1254 pretreated rats
after VCM exposure, and in animals exposed to
other halogenated hydrocarbons including carbon
tetrachloride and halothane (10). The enhanced
hepatotoxic potential ofcarbon tetrachloride and of
halothane in animals pretreated with inducers ofthe
mixed function oxidase system is considered related
to enhanced rates of their activation to reactive in-
termediates (possibly free radicals) by components
of this system (10, 11).
Carbon tetrachloride causes selective deactiva-
tion of specific mixed function oxidase system
components (12). It is not clear whether this occurs
as a direct consequence of molecular attack by the
reactive intermediate or as a consequence of lipid
peroxidation ofthe membrane (10). We have found
that exposure to VCM or TRI results in selective
deactivation ofmixed function oxidase components
including cytochrome P450 (13, 14). Table 1 com-
pares the effects of exposure to l,1-DCE, TRI and
halothane on cytochrome P450 and b5 contents at
the end of exposure. While TRI exposure caused a
loss of both cytochrome P-450 and b5, and
halothane exposure caused a loss of cytochrome
P450, 1,1-DCE exposure did not diminish contents
of either cytochrome P450 or b5. Note that each
combination of pretreatment and halocarbon expo-
sure shown in this table resulted in injury to the
liver.
Table 1. Contents of rat liver microsomal cytochromes P-450 and
b5 at end of chlorinated hydrocarbon exposure.
Cytochrome, nmole/mg protein"
Pretreatment Exposure P-450 b5
None Air 0.76 + 0.03 1.19 ± 0.04
None l,l-DCE" 0.73 + 0.08 1.22 + 0.08
PBT Air 2.50 ± 0.06 1.64 ± 0.10
PBT TRI' 1.87 ± 0.11" 1.29 ± 0.06e
Aroclor 1254 Air 2.66 ± 0.03 1.29 ± 0.06
Aroclor 1254 Halothanef 2.00 ± 0.07d 1.26 ± 0.06
aMeans + SEM, for three or more animals per group.
bo.02% 1,l-dichloroethylene, 4 hr.
cl% trichloroethylene, 2 hr.
dp < 0.001 compared to similarly pretreated animals exposed
to air.
ep < 0.05 compared to similarly pretreated animals exposed to
air.
fO.85% halothane, 5 hr.
Similarities in Biologic Response
Because the chloroethylenes are each members
of the same chemical family, certain similarities in
biologic response were expected and found. All
of the chlorinated ethylenes (including cis- and
trans-1,2-DCE) have been reported to be me-
tabolized by isolated perfused livers (15). Met-
abolic studies in vivo, in perfused livers, and/or
in vitro have shown that the biotransformation of
each chloroethylene results in the production of a
relatively stable oxidized metabolite such as an acid
or alcohol (3, 15-17). The nature of the oxidized
metabolites formed via the biotransformation of
each of the chlorinated ethylenes with chlorine(s)
attached to both carbons is compatible with the re-
arrangement of an epoxide (oxirane) intermediate
involving chlorine migration (15, 16). VCM, 1,1-
DEC, TRI, and PER are all capable of being acti-
vated by liver preparations (or perhaps are naturally
sufficiently reactive) to bind to hepatocellular ma-
cromolecules (15, 18-20). In vitro covalent binding of
'radiolabeled VCM or TRI in microsomal activation
systems can be minimized by addition of inhibitors
of the mixed function oxidase system (20, 21).
Environmental Health Perspectives 142Further evidence that the chlorinated ethylenes
can be activated to reactive molecules are the com-
parative mutagenic tests of Greim et al. (22). Each
of the nonsymmetric chlorinated ethylenes (VCM,
l,l-DCE, and TRI) was found to be activated to a
bacterial mutagen by NADPH-dependent mi-
crosomal generating systems. In contrast, no
mutagenic activity was detected for the sym-
metrically chlorinated ethylenes, cis- and trans-
1,2-DCE, and PER. The mutagenicity of non-
symmetric chloroethylenes, such as VCM, appears
related to electrophilic metabolites, since VCM
metabolites, chloroethylene oxide, 2-chloro-
acetaldehyde, and 2-chloroethanol-but not
chloroacetic acid-are mutagenic (23).
VCM, l,l-DCE, and TRI are classified as car-
cinogens: VCM exposure in man and experimental
animals is associated with angiosarcoma (24, 25).
I,I-DCE exposure results in kidney tumors in mice
(26), and TRI feeding leads to hepatic tumors in
mice (27).
Reduced glutathione (GSH) is involved in some
way in the biologic response to VCM, I,1-DCE,
and TRI. This relationship was first noted for 1,1-
DCE by Jaeger et al. (28), who found that fasting
and other treatments which deplete hepatic GSH
enhance the hepatotoxicity of l,l-DCE. TRI also
causes more extensive liver injury in fasted-PBT
pretreated animals than in fed-PBT pretreated ani-
mals (14). We have examined the relationship of
1,l-DCE-induced depletion of hepatic GSH to the
manifestation of early liver injury by quantifiable
compositional parameters such as changes in he-
patic metal contents. As shown in Figure 5, liver
GSH contents rapidly plummet during the first 2 hr
of l,I-DCE exposure. Concomitant with this drop,
Na contents rise. Striking increases in liver Ca
content follow the increases in liver Na at times
when GSH contents slowly rebound. In contrast,
K, Mg, and Zn contents decrease moderately in
concert.
Interestingly enough, liver metals have also
proved to be sensitive indicators of the progressive
hepatocellular derangement caused by TRI. As
shown in Figure 6, the pattern of metal change is
different than with l,l-DCE, with an initial loss in
liver Ca during TRI exposure, followed at later
times by the typical metal imbalances, specifically
Na and Ca influx and K loss, found after the ad-
ministration of other hepatotoxins such as CCI4
(12). As shown in Figure 7, we have found that in
PBT animals which are vulnerable to the
hepatotoxicity of TRI, liver GSH contents are
progressively depleted during TRI exposure, then
rise above normal levels (14). However, TRI expo-
sure to vehicle-pretreated animals does not result in
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FIGURE 5. Alterations in liver metal and GSH contents of non-
pretreated fasted rats during and after exposure to I, I-DCE
(0.02%, 4 hr) expressed as percentage of control values ob-
tained from similarly pretreated animals sacrificed at equiv-
alent times during the 12 hr experimental period: (0) Na; (A)
K; (o) Mg; (0) Zn; (o) Ca; (*) GSH. During the first 2 hr of
IJ.-DCE exposure GSH contents rapidly plImmet con-
comitant with an increase in Na content. By the end of
l.I-DCE exposure Ca, K. Mg, and Zn contents deviated
significantly (p < 0.05) from the control values. The dramaitic
influx in Cat continued to 12 hr. Na contents peaiked at 6 hr,
and the decreatse in Zn, K. and Zn reached ai plateau in con-
cert after the 4 hr. GSH contents were clearly being re-
plenished as the injury, reflected by the marked metal imbal-
ance, became manifest.
detectable liver injury and does not deplete liver
GSH contents. Nevertheless, liver GSH contents
progressively rise following exposure. GSH deple-
tion in TRI-exposed, PBT-pretreated rats is par-
ticularly marked in the microsomal fraction, the or-
ganelle which appears profoundly affected in the
hepatotoxic course ofTRI. VCM exposure has also
been associated with progressive depression of
hepatic contents of GSH (29).
In vitro covalent binding of '"C-VCM or TRI to
cellular macromolecules by microsomal generating
systems is diminished by the addition of GSH and
approximately doubled by the addition of tri-
chloropropene oxide (20, 30). It should be pointed
out that while trichloropropene oxide is a potent
inhibitor ofepoxide hydrase in itro, it also depletes
hepatic GSH in litro (31).
Figure 8 shows schematically the probable and
potential pathways ofTRI biotransformation. Acti-
vation ofTRI via a NADPH-P-450 system leads to
an epoxide which can rearrange to an aldehyde and
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FIGURE 6. Alterations in liver metal contents of PBT-pretreated
animals exposed to TRI (1%, 2 hr) expressed as percentage
of control values obtained from similarly pretreated
animals exposed to room air and sacrificed at equivalent
times during the 14 hr experimental period. Ca contents are
diminished nearly half by the end of exposure. The metal
imbalance at 8 and 14 hr, influx of Na and Ca coupled with
loss of K, is similar to that found after administration ofother
hepatotoxins such as CCl, (12). Data from Reynolds and
Moslen (9).
be hydrolyzed and transformed by other enzyme
systems to trichloroacetic acid or to trichlo-
roethanol, which is subsequently conjugated with
glucuronide to form the major urinary metabolite.
Fernanidez et al. (32) concluded from the low recov-
ery of TRI and its metabolites in the breath and
urine of human subjects that "other metabolites
exist, or that eventually other means ofelimination
occur." Our findings on the alterations of hepatic
GSH contents during and after TRI exposure indi-
cate some involvement of GSH in TRI bio-
transformation (14), perhaps via GSH transferases.
Other members ofthe chloroethylene family may
be biotransformed more extensively by minor
metabolic routes. For example, trichloroacetic acid
is the major metabolite ofPER, presumably formed
via epoxidation followed by a chloride shift pro-
ducing an acid chloride which would be rapidly
hydrolyzed to trichloroacetic acid (16). Formation
of the major urine-excreted metabolites of VCM;
i.e., thiodiglycollic acid and cysteine conjugates,
was reported to involve GSH by Green and Hath-
way (33). Bolt et al. (18) have suggested that the
coupling of reactive VCM metabolites to
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FIGURE 7. Alterations in liver GSH contents of (in) PBT-
pretreated and (.) vehicle-pretreated animals during and after
TRI exposure (1%, 2 hr). The GSH content of the PBT-
pretreated animals is progressively depressed to almost half
the pre-exposure levels by the end ofTRI exposure and then
rebounds. GSH contents of vehicle pretreated animals are
essentially constant during exposure, then rise to above pre-
exposure levels. Asterisks (*) denote statistically significant
points (p < 0.05). Data from Moslen et al. (14).
glutathione may be viewed as an alternate metabolic
pathway which prevents binding to cellular ma-
cromolecules, and may have particular significance
in preventing the reactions with nucleic acids.
Watanabe et al. (34) have recovered 9-13% of the
given doseof '4C-VCMasexhaled '4C02. It is not
clear at what point, or which intermediate, in the
biotransformation of chloroethylenes leads to the
breakdown of the chloroethylene carbon to carbon
bond.
Essentially the biologic response to the
chloroethylenes must be considered as a series of
steps as shown in Figure 9. Biotransformation re-
quires uptake into the cell and into specific or-
ganelles, interaction with an enzyme system,
metabolic activation and transformation, perhaps
subsequent rearrangements or enzymatic conj'uga-
tions, and ultimately excretion. Ifepoxidation is the
essential reaction in the biotransformation of a
chloroethylene to a hepatotoxin, then any pretreat-
ment or condition (such as induction of P-450)
which promotes or enhances this epoxidation step
(K'8) could be considered "synergistic" to the
hepatotoxic effect. Similarly synergistic is any pre-
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FIGURE 8. Biotransformation of trnchloroethylene is assumed to
occur chiefly along the metabolic route indicated by the
larger arrows. Ns1ADP'-I dependent oxidation by cytochrome
P-450 produces an epoxide as the primary metabolite which
rearranges by chloride migration to forn trichloroacetal-
dehyde as the major secondary metabolite. Trichloroacetal-
dehyde is converted to a tertiary generation of metabolites
through hydration, enzymatic oxidation, and enzymatic re-
duction to an alcohol. Trichloroethanol subsequently is con-
jugated to a glucuronide, the major urinary metabolite. Smaller
arrows indicate possible minor metabolic routes such as
GSH epoxide transfer which may account for the apparent
involvement of GSH in the biotransformation of TRI (14).
Other members of the chloroethylene family may be
metabolized to a greater extent by minor metabolic routes
due to the comparative stability/instability of the respective
chloroethylene molecule or its intermediates (16, 33, 34).
treatment or condition hampering the processes,
such as glucuronidation (k12) or GSH conjugation
(k11), which transform reactive intermediate(s) to
less toxic species. In contrast, conditions or pre-
treatments "antagonistic" to the hepatotoxic effect
would be those which increase the concentration (or
the capacity to renew supplies) of endogenous pro-
tective species such as glutathione (k5) which "de-
fend" cellular components against "attack" by
reactive molecular species.
Obviously the fundamental reactivity/stability of
the molecule has an influence on its biologic course.
VCM, TRI, and PER apparently require metabolic
activation before their hepatotoxic potential can be
expressed. 1I,l-DCE, in contrast, because of the
extensive electron depolarization due to the at-
tachment of2 chlorines on one carbon (Fig. 1), may
react spontaneously with endogenous electrophiles
of the cell such as iron in the cytochromes of elec-
tron transport systems of mitochondria and other
organelles. GSH may play a vital antagonistic role
in the biologic response to 1,l-DCE by protecting
vulnerable macromolecules against attack by this
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FIGURE 9. Kinetic flow diagram of the cellular response to a
xenobiotic. Xenobiotics must first pass through the cell
plasma membrane (PM) by a reversible process (k1, k2) then
interact with functional components of the endoplasmic re-
ticulum (k3, k,), with glutathione (GSH) in the cell sap (k5)
leading to a glutathione conjugate, or with other organelles
(k6, k7) leading (k,9) to a product XY. Interaction with the
mixed function oxidase system of the endoplasmic reticulum
(k8) is assumed to lead to generation of a reactive epoxide
capable of interaiction with vital cell components (k,,). Hy-
dration (k,,, conjugation (k11l k,2) and rearraingement (Ak:,)
transform the epoxide intermediate presumably to less toxic
compounds. However compounds formed subsequently,
such as aldehydes, may also be capable of toxic interaction
with cell components (k16) until further converted to acids
(k,1), alcohols (k,1), or glucuronide conjugates (k5. k17). In-
duction ofthe pathway (k8) which generates the toxic epoxide
species and conditions which reduce the efficiency of path-
ways which detoxifv the reactive species (kl0, kiI. k12, k15, k,8,
k19) would be considered synergistic to hepatotoxicity, since
the result is an enhancement of the hepatotoxic action (k,,).
Conditions which promote biotransformation by other en-
zymatic processes, such ask6, or maintainadequate GSH (k5)
contents would be considered antagonistic, since the result is
a diminution of hepatotoxic action.
highly depolarized molecule.
Delocalization of electrons of I,l-DCE away
from the chlorines may activate the molecule to-
wards a nucleophilic attack of such a nature that a
chlorine is replaced by an attacking nucleophile (1).
Epoxidation of I,l-DCE may be a relatively unim-
portant metabolic route or in fact may not occur.
Bonse et al. (15) reported a high uptake of 1,1-DCE
by isolated perfused rat liver but did not determine
the metabolites formed, although they were able to
identify di- and trichlorinated acid and/or alcohol
metabolites of 1,2-cis- and trans-dichloroethylene,
TRI and PER. Bonse et al. (15) were able to syn-
thesize the epoxide (oxirane) of all chlorinated
ethylenes except 1,l-DCE. Leibman and Ortiz (17)
have identified monochloroacetic acid as a product
of the biotransformation of 1,l-DCE by rat liver
9000g supernatant fractions and an NADPH
generating system. We have detected monochlo-
roacetic acid but not dichloroacetic acid in the urine
December 1977 145of animals exposed to 1,l-DCE (Reynolds et al.,
unpublished observation).
Is it possible that monochloroacetic acid is pro-
duced from 1,I-DCE not via cytochrome P-450
generated epoxide, but via a dechlorinating system
requiring cytochrome P-450, NADPH, 02 and
perhaps GSH? Van Dyke and colleagues (35, 36)
have demonstrated a microsomal dechlorinating
system that is inducible by PBT, preferentially de-
chlorinates compounds with more than one chlorine
attached to a carbon, produces oxidized metabolites
including acids and alcohols, and can be reconsti-
tuted with cytochrome P-450, NADPH cyto-
chrome c reductase, and lecithin. Multiple cyto-
chrome P-450 species with varying substrate
specificities, markedly different catalytic proper-
ties, and preferential inducibility are known (37).
Pretreatments which induce cytochrome P450 may
be antagonistic to the hepatotoxicity of 1,I-DCE
(Fig. 2, center) because the essential reaction ofthe
cytochrome P450 system on 1,l-DCE is a detox-
ifying dechlorination, not a toxifying epoxidation
as for VCM, TRI, and PER.
This report describes experimental studies conducted over
several years which involved at various stages the active collab-
oration of Drs. Rudolph J. Jaeger, Sandor Szabo, and Paul J.
Boor. We would also like to thank Elizabeth A. Gasch, Regina
Bean, Richard J. Treinen, and Theresa Paolini Kingsley for their
skillful assistance.
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AM-19814 from the National Institutes of Health.
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